Chi­na biotech start­up In­ven­tis­Bio bags a $19M round for ear­ly-stage R&D

The flow of ven­ture cash in and out of Chi­na’s biotech scene in­cludes a new $19 mil­lion round to­day for Shang­hai-based In­ven­tis­Bio, which has been …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA